Systems-level engineering of T-cell specificity
On 1 and 2 December 2026, the European Association for Cancer Research runs a virtual conference on T-cell specificity. The meeting asks how T-cells tell cancer cells apart from healthy tissue. Immunotherapy has transformed parts of oncology, yet many tumours still fail to respond. Stronger immune activation also carries a risk of immune-related toxicity. The programme covers T-cell receptor specificity, T-cell engineering, and T-cell control of cancer.
EACR aims the meeting at basic, computational, translational and clinical scientists. Immunology, cancer biology, cell therapy, systems biology and machine learning all fall within scope. The format suits early-career and established researchers alike.
Abstract submission for posters and short talks closes on 19 October 2026. Registration and payment close on 16 November 2026. Rates run from €60 for EACR student members to €300 for industry non-members. The registration page carries the full fee structure and key dates.
